Cannabis ETF Surges as Trulieve's NYSE Debut Tests Sector's Uplisting Bet
Money is flowing into cannabis equities at a pace the sector hasn't seen in years, and the trigger isn't a new product launch or a state legalization vote - it's a paperwork question in Washington.